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Summary and Conclusions 
Bacteriocins are inhibitory peptides produced by a number of Lactic Acid Bacteria capable of 
killing other bacteria. These natural inhibitors have widespread applications in the 
preservation of foods, since they can kill a number of pathogenic and spoilage bacteria. A 
novel broad spectrum bacteriocin designated lacticin 3147was discovered as part of this 
project. The bacterial strain which produces lacticin 3147 (Lactococcus 
lactissubsp.lactisDPC3147) is food-grade and similar to strains used for commercial cheese 
making. Lacticin 3147 is effective in the inhibition of all Gram-positive bacteria tested 
including the food pathogens Listeria monocytogenes and Staphylococcus aureus and food 
spoilage bacteria such as Clostridiaand Bacillus species. In a collaborative effort between 
the Microbiology Department, UCC and the Dairy Products Research Centre, Moorepark a 
detailed genetic and biochemical characterisation of this bacteriocin has been performed, 
which demonstrates that it is a unique bacteriocin composed of two individual peptides. The 
genetic determinants encoding lacticin 3147 have been transferred to a range of lactococcal 
starter cultures, conferring on these strains the ability to control the microflora of fermented 
products, through the production of the bacteriocin. For example lacticin 3147 producing 
starters have the ability to reduce or eliminate non-starter lactic acid bacteria during cheese 
ripening, or to eliminate the pathogen Listeria monocytogenes from certain susceptible 
varieties of cheese. (The elimination of L. monocytogenesis of extreme importance given 
that the fatality rate for individuals infected with this organism is 30-40%). 
In a different study, a narrow spectrum bacteriocin producer which secretes three 
bacteriocins (lactococcin A, B and M) was used in the manufacture of Cheddar cheese. The 
combined effect of the three bacteriocins induced lysis of the companion starter cells, 
resulting in release of intracellular enzymes. Increased starter cell lysis resulted in improved 
flavour development and accelerated cheese ripening, thereby potentially offering a 
substantial saving to the manufacturers of ripened cheeses. 
Hence the objectives of this project were to generate, characterise and exploit a range of 
novel bacteriocin producing starter cultures to improve both the safety and the quality of 
fermented dairy foods. 
The main conclusions were as follows: 
 Lacticin 3147 is a broad spectrum bacteriocin which inhibits a wide range of Gram-
positive bacteria including lactobacilli, clostridia and Listeria.  
 The bacteriocin has been purified by chromatographic procedures and has been 
shown to be composed of two peptides, both of which are required for biological 
activity.  
 The mechanism of action of lacticin 3147 has been elucidated.  
 The entire plasmid encoding lacticin 3147 has been sequenced and the bacteriocin in 
distinct from any previously characterised lactococcal bacteriocin.  
 The Food Grade introduction of the bacteriocin genes into cheese starters was 
carried out.  
 Lacticin 3147 producing starters have been used to control the pathogen Listeria 
monocytogenes on the surface of mould ripened cheese.  
 Lacticin 3147 producing starters have been used to control the non-starter lactic acid 
bacteria complement in Cheddar cheese during the ripening process.  
 A novel starter system using a bacteriocin (lactococcin)- producing adjunct has been 
designed which gives increased cell lysis during Cheddar cheese manufacture while 
ensuring that efficient acid production is not compromised.  
In summary these studies have found that naturally occurring antimicrobials such as 
bacteriocins have a wide range of applications in the food industry for improving both the 
quality and safety of fermented dairy products. 
 
Lactococcus lactis subsp. lactis DPC3147 colonies on an agar plate showing zones of 
inhibition due to the presence of the bacteriocin lacticin 3147. 
  
Research and Results 
Spectrum of Lacticin 3147 Activity 
Lacticin 3147 has a broad spectrum of activity and inhibits all Gram-positive bacteria tested 
to date including potential food-borne pathogens such as staphylococci, clostridia, and 
Listeria. In addition, lacticin 3147 is effective at killing all mastitic staphylococcal and 
streptococcal isolates tested including Staphylococcus aureus,Streptococcus dysgalactiae, 
Strep. agalactiae and Strep. uberis. However, lacticin 3147 is not effective at killing Gram-
negative bacteria. 
 
These results demonstrate that lacticin 3147 has a broad spectrum of inhibition capable of 
inhibiting all Gram-positive bacteria tested including food-borne pathogens (in red). 
Physical properties 
Like most other proteins lacticin 3147 is sensitive to proteolytic enzymes including digestive 
enzymes. Treatment of preparations of lacticin 3147 with trypsin, a-chymotrypsin, proteinase 
K and pronase E, inactivated this bacteriocin. Lacticin 3147 is also extremely active over a 
wide pH range, including physiological pH and thus, unlike nisin should prove to have a 
number of applications in foods with pH close to neutrality. Lacticin 3147 is also extremely 
heat resistant, particularly at low pHs and can withstand autoclaving temperatures. 
The bacteriocin has been purified by chromatographic procedures and has been shown to 
be composed of two peptides, both of which are required for biological activity. 
 Component A and B required for activity shown here on a chromatogram. 
(SPLC apparatus used to purify LACTICIN 3147) 
 
 
Inhibitory activity demonstrated when compenent A and B are combined. 
Results indicate that lacticin 3147 is active over a wide pH range, including physiological pH, 
and that its activity is dependent on the presence of two peptides. 
Mechanism of action 
Lacticin 3147 elicits a bactericidal effect on sensitive cells by first interacting with the cell 
membrane. This causes the membrane to become porous for K+ and inorganic phosphate 
which leak out of the cells. In an attempt to re-accumulate these ions, ATP-dependent 
uptake systems lead to hydrolysis of internal ATP. As ATP is required for the maintenance of 
essential cellular functions, such as the pH gradient at the cell membrane, cellular functions 
are disrupted and the cell eventually loses energy and dies. 
 
A schematic diagram showing the mechanism of action of lacticin 3147. 
Lacticin 3147 induces cell death by causing the membranes of sensitive cells to become 
porous to K+ and inorganic phosphate. 
Genetics of lacticin 3147 production and immunity 
Lacticin 3147 is encoded in Lactococcus lactis ssp. lactis 3147 on a piece of DNA which lies 
outside its chromosome, called a plasmid. The plasmid which encodes lacticin 3147 
production and immunity has been designated pMRC01. This plasmid can readily be mated 
between different lactococcal strains, in a food grade manner. The entire nucleotide 
sequence of this 60,232 bp pMRC01 plasmid was determined, representing the largest 
lactococcal plasmid sequenced to date. Detailed analysis of the genetic loci involved in the 
production of lacticin 3147 are provided in the paper by Dougherty et al., 1998. A synopsis of 
these data is provided here. 
 Map of pMRCO1, which can be divided into a number of basic components delineated by 
insertion sequences (IS): a region encoding conjugative functions; a region encoding phage 
resistance and plasmid replication and maintenance; and a region encoding lacticin 3147 
production and immunity functions. The lacticin 3147-encoding region is flanked by two iso-
ISS1 elements and contains 10 open reading frames (ORFs), which are believed to be 
associated with bacteriocin functions. 
Knowledge of the DNA sequence permits genes to be identified, which in turn allows the 
sequence of amino acids in the proteins produced to be determined. In many cases, the 
function of these genes and the products they encode can be inferred by comparing the 
DNA or deduced protein sequences with known sequences present in databases. 
Comparative sequence analysis coupled with experimental data has permitted the region of 
plasmid pMRC01 required for bacteriocin activity to be identified and up to 10 genes are 
believed to be directly associated with lacticin 3147 activity. These genes are arranged in 
two clusters with ltnA1, ltnA2, ltnM1, ltnT, ltnM2 and ltnD transcribed in the same direction 
and ltnH, ltnJ, ltnF and ltnE transcribed in the opposite direction. 
The first genes in the larger cluster, ltnA1 and ltnA2, encode two relatively short peptides 
which are most likely the precursor of the active lacticin 3147 bacteriocin. These peptides 
are probably required to undergo a number of modifications before they are activated. The 
ltnM1 and ltnM2 gene products (modification proteins) are likely to perform this role. Lacticin 
3147 is unusual in that to date it is the only bacteriocin known to have two modification 
proteins, a feature presumably linked to the two different peptide components of the active 
bacteriocin. After the LtnA1 and LtnA2 peptides have been modified the cell needs to export 
them to the exterior so that the bacteriocin can mediate its effect against other organisms. 
Transport is probably mediated by an ABC (ATP Binding Cassette ) transporter which is 
encoded by ltnT. If the concentration of lacticin 3147 in the immediate vicinity of the producer 
cell gets too high, it may kill the producer cell. To prevent this, the producer cell has to have 
a certain level of immunity or resistance to its own bacteriocin. Immunity is probably provided 
(at least in part) by the products of ltnE and ltnF. The gene product of another gene, ltnH, 
has characteristics of a regulatory protein which binds to DNA indicating that the cell has a 
control mechanism to alter expression of the genes associated with bacteriocin activity. The 
function of the two genes, ltnD and ltnJ is unknown, however, their genetic location suggests 
that they are associated with lacticin 3147 functions. 
Lacticin 3147 is encoded by the conjugative plasmid designated pMRC01. The lacticin 3147 
region codes for at least 10 proteins, which are believed to be associated with bacteriocin 
functions. 
Introduction of the bacteriocin genes into cheese starters 
The food grade introduction of the bacteriocin genes into cheese starters was carried out, by 
a bacterial mating process known as conjugation. This is made possible by the fortuitous 
association of the bacteriocin genes with a plasmid which can be transferred between 
strains. Conjugation experiments revealed that the presence of lacticin 3147 in media is 
sufficient to select for the presence or absence of the associated immunity gene(s). Genetic 
determinants which encode lacticin 3147 immunity thus provide an excellent tool as a food 
grade marker for the development of improved starters. This research has resulted in the 
generation of a range of novel starters which now both produce and are immune to lacticin 
3147. 
When grown in milk these strains now secrete the bacteriocin into their environment, 
resulting in fermented products such as cheese, which contain the inhibitor, lacticin 3147. 
Since lacticin 3147 is produced naturally by the starter culture in the product, it is not 
considered a food additive and therefore does not require labelling. One of the lacticin 3147 
producing starters has been evaluated in the production of Cheddar cheese, low fat cheese, 
Cottage cheese and mould ripened cheese. In each case the lacticin producing starter was 
used to either improve cheese quality or improve cheese safety. 
 
A schematic drawing showing the development of a food grade marker system based on 
lacticin 3147. 
1. An example of a lacticin 3147 producing starter used to improving cheese quality. 
In cheeses such as Cheddar, it is desirable that the manufacturer has control over flavour 
development. Since non-starter lactic acid bacteria have been implicated in off flavour 
defects, control of their growth is desirable. Trials carried out with a bacteriocin producing 
starter demonstrated that after six months of ripening non-starter counts were at a low 
enough level that they would not interfere with flavour development. The use of bacteriocin 
producers to control the growth of advantageous bacteria gives the manufacturer control of 
flavour development in cheese, and prevents economic losses which may occur if off 
flavours develop. A new project aimed at further exploiting lacticin 3147 for Cheddar cheese 
uses is currently underway. 
In Cheddar cheese manufactured with a lacticin 3147 producing starter substantial amounts 
of bacteriocin (1,280 AU/ml) was detected in the cheese. The presence of the bacteriocin 
correlated with a reduction in non-starter lactic acid bacteria numbers. 
 
Figure showing the inhibition of non-starter lactic acid bacteria (NSLAB) growth in Cheddar 
cheese manufactured in the presence and absence of a lacticin 3147 producing starter. 
 
Bacteriocins may offer cheeesemakers more control over which bacteria proliferate in 
cheese. 
2. An example of a lacticin 3147 producing starter used to improving cheese safety. 
Certain mould ripened cheeses may be at risk of contamination with pathogenic bacteria 
such as Listeria. During ripening the pH at the surface of these cheeses can excede pH 7, 
which provides a suitable environment for the proliferation of many undesirable bacteria 
such as Listeria. Trials have been carried out whereby a lacticin 3147 producer applied to 
the surface of a mould ripened cheese resulted in effective killing of Listeria. Here again an 
opportunity exists for manufacturers to benefit from the use of a natural antimicrobial to 
control the micro-flora present in cheese. 
 Figure showing the inhibition of Listeria on mould ripened cheese manufactured in the 
presence and absence of a lacticin 3147 producing starter. 
 
Fear of contamination of mould ripened cheeses with Listeria monocytogenes can be 
eliminated through the use of the bacteriocin, lacticin 3147. 
Lacticin 3147 immunity has been used as a tool in the development of a food grade marker 
system for the development of improved starters. These lacticin 3147 producing starters, 
when used in Cheddar cheese manufacture, resulted in a reduction in non-starter lactic acid 
bacteria numbers. Lacticin 3147 producing starters were also effective at reducing the 
numbers ofListeriaon the surface of mould ripened cheese. 
Bacteriocins in accelerated cheese ripening 
The usefulness of bacteriocins in accelerated cheese ripening was also assessed as part of 
this project. A novel starter system using a bacteriocin producing adjunct (producing 
lactococcin A, B and M) has been designed which gives increased cell lysis during Cheddar 
cheese manufacture while ensuring that efficient acid production is not compromised. 
Cheddar cheese manufactured with the lactococcin A, B and M producer demonstrated 
higher concentrations of intracellular enzymes, indicating that increased starter cell lysis had 
occurred during manufacture and ripening. These cheeses also exhibited higher levels of 
free amino acids, indicating that a greater degree of secondary proteolysis had occurred. In 
addition, Cheddar manufactured with the bacteriocin producing adjunct were awarded higher 
grading scores than control cheeses. 
This novel starter system using a bacteriocin (lactococcin)- producing adjunct has been 
designed to give increased starter cell lysis during Cheddar cheese manufacture. Cheeses 
manufactured with the bacteriocin producing adjunct were favoured during commercial 
cheese grading. 
A diagram showing how the lactococcin A, B and M producer, when used as an adjunct to 
the acid producing starter culture, induces lysis of the starter cells. 
 
 
Increased starter cell lysis in cheeses manufactured with the bacteriocin producing adjunct 
resulted in these cheeses being favoured during commericial cheese grading. 
 List of Publications 
Morgan, S., Ross, R.P. and Hill, C. (1995) Bacteriolytic activity caused by the presence of a 
novel lactococcal plasmid encoding lactococcins A, B, and M. Appl. Environ. Microbiol. 
61:2995-3001. 
Ryan, M.P., Rea, M.C. and Ross, R.P. (1995) Bacteriocins. Patent Application (Application 
No. 5950269). 
Morgan, S. (1995) Characterisation of a narrow spectrum L.lactis bacteriocin producer and 
its application in the acceleration of Cheddar cheese ripening. Ph.D. thesis (University 
College Cork). 
Ryan, M.P., Rea, M.C., Hill C. and Ross, R.P. (1995) Characterisation and application of 
Lacticin 3147, a novel broad-spectrum bacteriocin produced by Lactococcus lactis. Irish 
Journal of Agricultural and Food Research; Vol. 34, pp217 (Abstract). 
Morgan, S., O'Donovan, C., Ross, R.P., Hill, C. and Fox, P.F. (1995) Significance of 
autolysis and bacteriocin-induced lysis of starter cultures in Cheddar cheese ripening. In: 4th 
Cheese Symposium, Teagasc, Fermoy, Co. Cork, pp51-60. 
Ryan, M.P. (1995) Characterization of a novel bacteriocin produced by a Lactococcus lactis 
subsp. lactis strain isolated from an Irish kefir grain. M.Sc. thesis (University College Cork). 
Ryan, M.P., Rea, M.C., Hill, C. and Ross, R.P. (1996) An application in Cheddar cheese 
manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, 
lacticin 3147. Appl. Environ. Microbiol. 62 pp612. 
Dodd, S.D. (1996) Sensitivity and tolerance of Lactococcus Sp. And Listeria monocytogenes 
Scott A to lacticin 3147. M.Sc. thesis (University College Cork). 
Ross, R.P. Say it with cheese. Food Ireland, March. 
Morgan, S., Murray, D., Ross, R. P. and Hill, C. (1996) Application of a bacteriocin-producing 
lactococcal strain in the acceleration of Cheddar cheese ripening. In Proceedings of the fifth 
symposium of lactic acid bacteria: genetics, metabolism and applications. C21 (Abstract), 
FEMS publication. 
Ryan, M.P., McAuliffe, O., Rea, M., Hill, C. and Ross, R.P. (1996) Characterization of a 
novel broad-spectrum bacteriocin, lacticin 3147 and its application in cheese manufacture. In 
Proceedings of the fifth symposium of lactic acid bacteria: genetics, metabolism and 
applications. C22 (Abstract), FEMS publication. 
Morgan, S., Ross R.P. and Hill, C. (1996) Increasing starter cell lysis in Cheddar cheese 
using a bacteriocin-producing adjunct. J. Dairy Sci. 80:1-10. 
Dougherty, B., Hill, C., Weidman, J.F., Richardson, D.R., Venter, J.C., and Ross, R.P. 
(1998) Sequence and analysis of the 60 kb conjugative, bacteriocin producing plasmid 
pMRC01 from Lactococcus lactis DPC147. Mol. Microbiol.., 29, 1029 - 1038. 
McAuliffe, O., Ryan, M.P., Ross, R.P., Hill, C., Breeuwer, P. and Abee, T. (1998) Lacticin 
3147: a broad spectrum bacteriocin which selectively dissipates the membrane potential. 
Appl. Environ. Micro. 64:439-445. 
Ryan, M.P., Meaney, W.J., Ross, R.P. and Hill, C. (1998) Evaluation of lacticin 3147 and a 
teat seal containing the bacteriocin for the inhibition of mastitis pathogens. 64, 2287 - 2290. 
Coffey, A.G., Fitzgerald, G.F. and Ross, R.P. (1997) Molecular Biology of starter cultures: 
has it paid off? In 5th Cheese Symposium, (Cogan, T.M., Fox, P.F. and Ross, R.P., eds.), 
Teagasc, Moorepark, Fermoy, Co. Cork, Ireland, 42-52. 
Cunniffe, A., Hill, C. and Ross, R.P. (1997) Isolation and identification of bacteriogenic 
strains from Irish raw milk samples. Irish Journal of Agricultural and Food Research; Vol. 35, 
pp192 (Abstract). 
Murray, D., Hill, C. and Ross, R.P. Design of a novel bacteriocin-producing starter system to 
accelerate Cheddar cheese ripening. Irish Journal of Agricultural and Food Research; Vol. 
35, pp189 (Abstract). 
Hill, C., Ryan, M., McAuliffe, O., Abee, T., Dougherty, B. and Ross, R.P. Molecular 
characterization and mode of action of lacticin 3147, a two-component, broad host range 
bacteriocin active in food systems. In Functional Foods:Designer Foods for the Future, 
Teagasc, Moorepark, Fermoy, Co. Cork, Ireland, PBS 37 (Abstract). 
Meaney, B., Ryan, M., Flynn, J., Hill, C. and Ross, R.P. (1997). Mastitis control without 
antibiotics? Farm and Food; pp23-25. 
Meaney, B., Ryan, M., Flynn, J., Crilly, J., Hill, C. and Ross, R.P. (1997). New developments 
in the prevention of mastitis during the dry period. In International Conf. on Machine Milking 
and Mastitis; pp56-68. 
For Further Information, please contact: Dr. R. Paul Ross / Dr. Colin Hill 
 
